Related Experiment Videos
[Autologous blood transfusion in urology]
1Urologische Abteilung Stadtkrankenhaus, Klinikum Bismarckstrasse, Memmingen.
Der Urologe. Ausg. A
|March 1, 1989
Summary
This study shows that reinfusing autologous blood saved during urological surgery effectively reduces the need for homologous blood transfusions. Patients tolerated the cell saver technique and preoperative plasmapheresis well, minimizing risks associated with donor blood.
Area of Science:
- Urology
- Transfusion Medicine
- Surgical Hemostasis
Context:
- Urological surgeries like prostate resections and radical prostatectomies can involve significant blood loss.
- Managing intraoperative blood loss is critical for patient safety and outcomes.
- The need for homologous blood transfusions carries inherent risks.
Purpose:
- To evaluate the efficacy and safety of using a cell saver for autologous blood recovery and reinfusion in urological procedures.
- To assess the tolerance of preoperative plasmapheresis and autotransfusion.
- To determine the impact of autotransfusion on the requirement for homologous blood products.
Summary:
- Sixty-seven urological patients underwent procedures using a Haemonetics cell saver to collect, wash, and reinfuse autologous blood as erythrocyte concentrate.
- Preoperative plasmapheresis was performed to obtain autologous fresh frozen plasma (FFP) for substitution of lost plasma volume and clotting factors.
- Despite substantial blood losses (up to 4500 ml), only one patient required homologous blood transfusion, indicating high efficacy of the autotransfusion protocol.
Impact:
- Autotransfusion via cell saver and preoperative plasmapheresis significantly reduces the need for homologous blood in major urological surgeries.
- This approach enhances patient safety by minimizing exposure to allogeneic blood products.
- The study demonstrates a well-tolerated and effective strategy for blood management in high-risk surgical patients.